Advanced Parkinson's disease is characterized by the presence of motor fluctuations,
various degree of dyskinesia, and disability with functional impact on activities of daily living …

Deep brain stimulation (DBS) of the subthalamic nucleus (STN) or globus pallidum internus
(GPi) improves motor functions in patients with Parkinson's disease (PD) but may cause a …

Depression and anxiety are some of the most common comorbidities arising in patients with
Parkinson's disease. However, their timely recognition and diagnosis are often hindered by …

Parkinson's disease (PD) is the second leading neurodegenerative disease that is
characterized by severe locomotor abnormalities. Levodopa (L-DOPA) treatment has been …

Depression represents one of the most common non-motor disorders in Parkinson's disease
(PD) and it has been related to worse life quality, higher levels of disability, and cognitive …

Cognitive and behavioral symptoms are common in Parkinson's disease, may occur even in
the prodromal stages of the disease, worsen with disease progression, and surpass motor …

Deep brain stimulation (DBS) is an effective (but non-curative) treatment for some of the
motor symptoms and treatment complications associated with dopaminergic agents in …

Neurofeedback is a form of brain training in which subjects are fed back information about
some measure of their brain activity which they are instructed to modify in a way thought to …

Background: Subthalamic nucleus deep brain stimulation (STN-DBS) successfully controls
the motor symptoms of Parkinson's disease (PD) but has associated cognitive side-effects …

Deep brain stimulation (DBS) is a surgical treatment in which stimulation electrodes are
permanently implanted in basal ganglia to treat motor fluctuations and symptoms of …